TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Nihon Kohden Corporation ( (JP:6849) ) has issued an announcement.
Nihon Kohden Corporation has announced the termination of its distribution partnership with Abbott Medical Japan LLC, effective December 31, 2026, as part of its strategic business portfolio review. In response, the company is implementing two support programs: the Career Change Support Program for employees involved in the Abbott business, and the Next Career Support Program for employees seeking new career opportunities or early retirement. These initiatives are expected to result in extraordinary losses of approximately ¥2.4 billion in FY2025, but a reduction in SG&A expenses by around ¥2.3 billion in FY2026.
The most recent analyst rating on (JP:6849) stock is a Buy with a Yen1898.00 price target. To see the full list of analyst forecasts on Nihon Kohden Corporation stock, see the JP:6849 Stock Forecast page.
More about Nihon Kohden Corporation
Nihon Kohden Corporation is a company listed on the Prime Market of the Tokyo Stock Exchange, primarily involved in the medical technology industry. The company focuses on creating high added value products and services, aiming to transform into a global entity by 2030.
Average Trading Volume: 506,059
Technical Sentiment Signal: Hold
Current Market Cap: Yen284.1B
See more insights into 6849 stock on TipRanks’ Stock Analysis page.